| A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms (NCT01000805) | Eli Lilly and Company | 2009-11-01 |
| A Study of Advanced or Metastatic Non-small Cell Lung Cancer (NCT00988858) | Eli Lilly and Company | 2009-11-01 |
| Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes (NCT01107899) | Eli Lilly and Company | 2009-10-01 |
| A Study on the Effect of 2 Pen Devices on HbA1c (NCT00985712) | Eli Lilly and Company | 2009-10-01 |
| A Study of LY2189265 in Japanese Patients With Type 2 Diabetes (NCT01001104) | Eli Lilly and Company | 2009-10-01 |
| A Weight Loss Study in Overweight Men and Women (NCT00993421) | Eli Lilly and Company | 2009-10-01 |
| A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer (NCT01000480) | Eli Lilly and Company | 2009-10-01 |
| A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (NCT00970632) | Eli Lilly and Company | 2009-10-01 |
| A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer (NCT01004250) | Eli Lilly and Company | 2009-10-01 |
| A Study of LY2801653 in Advanced Cancer (NCT01285037) | Eli Lilly and Company | 2009-09-09 |
| Study of IMC-1121B in Patients With Advanced Solid Tumors (NCT01005355) | Eli Lilly and Company | 2009-09-01 |
| A Study for Japanese Participants With Rheumatoid Arthritis (RA) (NCT01253226) | Eli Lilly and Company | 2009-09-01 |
| A Study of Patients With Major Depressive Disorder and Residual Apathy (NCT00985504) | Eli Lilly and Company | 2009-09-01 |
| Major Depressive Disorder (MDD) (NCT01662817) | Eli Lilly and Company | 2009-09-01 |
| A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder (NCT00965419) | Eli Lilly and Company | 2009-09-01 |
| A Study of LY573636-sodium in Patients With Metastatic Breast Cancer (NCT00992225) | Eli Lilly and Company | 2009-09-01 |
| A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women (NCT01742091) | Eli Lilly and Company | 2009-09-01 |
| A Study of Olanzapine in Patients With Schizophrenia (NCT00970281) | Eli Lilly and Company | 2009-09-01 |
| A Study for Adult Patients With Fibromyalgia (NCT00965081) | Eli Lilly and Company | 2009-09-01 |
| Study in Adolescents With Schizophrenia or Bipolar Disorder (NCT00982020) | Eli Lilly and Company | 2009-09-01 |
| A Study of LY2624803 in Japanese Participants With Transient Insomnia (NCT01784614) | Eli Lilly and Company | 2009-09-01 |
| A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients (NCT00971997) | Eli Lilly and Company | 2009-09-01 |
| Study of Participants With Advanced Non-Small Cell Lung Cancer (NCT00948675) | Eli Lilly and Company | 2009-09-01 |
| A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder (NCT00960986) | Eli Lilly and Company | 2009-08-01 |
| Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder (NCT00962104) | Eli Lilly and Company | 2009-08-01 |
| A Study in Relapse Prevention of Treatment-Resistant Depression (NCT00958568) | Eli Lilly and Company | 2009-08-01 |
| Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma (NCT00917384) | Eli Lilly and Company | 2009-08-01 |
| A Study in Patients With Rheumatoid Arthritis (NCT00966875) | Eli Lilly and Company | 2009-08-01 |
| Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women (NCT00927186) | Eli Lilly and Company | 2009-07-01 |
| Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment (NCT00883051) | Eli Lilly and Company | 2009-07-01 |
| A Study of Duloxetine in Patients With Osteoarthritis Knee Pain (NCT00945945) | Eli Lilly and Company | 2009-07-01 |
| Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) (NCT00910299) | Eli Lilly and Company | 2009-07-01 |
| The Cymbalta Pregnancy Registry (NCT01074151) | Eli Lilly and Company | 2009-07-01 |
| A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder (NCT00922636) | Eli Lilly and Company | 2009-06-01 |
| A Study of LY2189102 in Patients With Type 2 Diabetes (NCT00942188) | Eli Lilly and Company | 2009-06-01 |
| Study of IMC-EB10 in Participant With Leukemia (NCT00887926) | Eli Lilly and Company | 2009-06-01 |
| A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer (NCT00913835) | Eli Lilly and Company | 2009-06-01 |
| A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab (NCT00845039) | Eli Lilly and Company | 2009-05-01 |
| Effect of LY2062430 on the Progression of Alzheimer's Disease (NCT00905372) | Eli Lilly and Company | 2009-05-01 |
| Effect of LY2062430 on the Progression of Alzheimer's Disease (NCT00904683) | Eli Lilly and Company | 2009-05-01 |
| A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver (NCT00906373) | Eli Lilly and Company | 2009-05-01 |
| A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer (NCT00887549) | Eli Lilly and Company | 2009-04-01 |
| Chemotherapy in Treating Patients With Lung Cancer (NCT01067794) | Eli Lilly and Company | 2009-04-01 |
| A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer (NCT00867009) | Eli Lilly and Company | 2009-04-01 |
| A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) (NCT00882999) | Eli Lilly and Company | 2009-04-01 |
| A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture (NCT00887354) | Eli Lilly and Company | 2009-04-01 |
| A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer (NCT00862784) | Eli Lilly and Company | 2009-04-01 |
| A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression (NCT00844857) | Eli Lilly and Company | 2009-04-01 |
| A Study of LY2405319 in Participants With Type 2 Diabetes (NCT01869959) | Eli Lilly and Company | 2009-04-01 |
| Study of Prasugrel in Korean Healthy Male Volunteers (NCT01591317) | Eli Lilly and Company | 2009-03-01 |
| A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers (NCT00848081) | Eli Lilly and Company | 2009-03-01 |
| A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia (NCT00855582) | Eli Lilly and Company | 2009-03-01 |
| A Study in the Treatment of Children and Adolescents With Major Depressive Disorder (NCT00849901) | Eli Lilly and Company | 2009-03-01 |
| A Study for Participants With Type 2 Diabetes Mellitus (NCT00871572) | Eli Lilly and Company | 2009-03-01 |
| A Study in the Treatment of Children and Adolescents With Major Depressive Disorder (NCT00849693) | Eli Lilly and Company | 2009-03-01 |
| Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT00861757) | Eli Lilly and Company | 2009-03-01 |
| A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before (NCT00870870) | Eli Lilly and Company | 2009-03-01 |
| Treatment for Aggression and Agitation in Patients With Alzheimer's Disease (NCT00843518) | Eli Lilly and Company | 2009-02-01 |
| An Open Label Extension Study in Participants With Rheumatoid Arthritis (NCT00837811) | Eli Lilly and Company | 2009-02-01 |
| A Study for Participants With Pancreatic Cancer (NCT00839332) | Eli Lilly and Company | 2009-02-01 |
| A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer (NCT00781911) | Eli Lilly and Company | 2009-02-01 |
| A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder (NCT00840034) | Eli Lilly and Company | 2009-02-01 |
| A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes (NCT00853151) | Eli Lilly and Company | 2009-02-01 |
| Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors (NCT00698841) | Eli Lilly and Company | 2009-02-01 |
| A Study in Erectile Dysfunction (NCT00833638) | Eli Lilly and Company | 2009-02-01 |
| A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome (NCT00830960) | Eli Lilly and Company | 2009-02-01 |
| A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer (NCT00735696) | Eli Lilly and Company | 2009-01-01 |
| Effect of Tadalafil Once a Day in Men With Erectile Dysfunction (NCT00836693) | Eli Lilly and Company | 2009-01-01 |
| Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors (NCT01214668) | Eli Lilly and Company | 2009-01-01 |
| Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily (NCT00827242) | Eli Lilly and Company | 2009-01-01 |
| Duloxetine for the Treatment of Generalized Anxiety Disorder (NCT00803361) | Eli Lilly and Company | 2008-12-01 |
| A Study for Patients With Type 2 Diabetes Mellitus (NCT00804986) | Eli Lilly and Company | 2008-12-01 |
| A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer (NCT00762034) | Eli Lilly and Company | 2008-12-01 |
| A Study in Adult Patients With Major Depressive Disorder (NCT00795821) | Eli Lilly and Company | 2008-12-01 |
| A Study in the Treatment of Alcohol Dependence. (NCT00805441) | Eli Lilly and Company | 2008-12-01 |
| A Study of Arzoxifene to Treat Korean Women With Osteoporosis (NCT00767299) | Eli Lilly and Company | 2008-12-01 |
| Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes (NCT00791479) | Eli Lilly and Company | 2008-12-01 |
| A Safety Study of LY2811376 Single Doses in Healthy Subjects (NCT00838084) | Eli Lilly and Company | 2008-12-01 |
| A Study in the Treatment of Osteoarthritis Knee Pain (NCT00790790) | Eli Lilly and Company | 2008-11-01 |
| A Study for the Treatment of Alcohol Dependence (NCT00804570) | Eli Lilly and Company | 2008-11-01 |
| Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension (NCT00783094) | Eli Lilly and Company | 2008-11-01 |
| Follow-up Data of Patients Treated With XIGRIS® in France (NCT00803231) | Eli Lilly and Company | 2008-11-01 |
| A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer (NCT00789373) | Eli Lilly and Company | 2008-11-01 |
| A Study of LY2584702 in Participants With Advanced Cancer (NCT01394003) | Eli Lilly and Company | 2008-11-01 |
| A Study for Treatment of Pain in Patients With Diabetic Neuropathy. (NCT00785577) | Eli Lilly and Company | 2008-11-01 |
| Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder (NCT00810069) | Eli Lilly and Company | 2008-11-01 |
| Study in Participants With Acute Migraines Headaches (NCT00804973) | Eli Lilly and Company | 2008-11-01 |
| A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations (NCT00857454) | Eli Lilly and Company | 2008-10-01 |
| A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy (NCT00785928) | Eli Lilly and Company | 2008-10-01 |
| An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia (NCT00784875) | Eli Lilly and Company | 2008-10-01 |
| Duloxetine for Multiple Sclerosis Pain (NCT00755807) | Eli Lilly and Company | 2008-10-01 |
| A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel (NCT00768131) | Eli Lilly and Company | 2008-10-01 |
| A Study of LY2228820 in Participants With Advanced Cancer (NCT01393990) | Eli Lilly and Company | 2008-09-04 |
| Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia (NCT00716274) | Eli Lilly and Company | 2008-09-01 |
| A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma (NCT00744991) | Eli Lilly and Company | 2008-09-01 |
| Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) (NCT00760747) | Eli Lilly and Company | 2008-09-01 |
| Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer (NCT00686959) | Eli Lilly and Company | 2008-09-01 |
| A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread (NCT01648764) | Eli Lilly and Company | 2008-09-01 |
| A Study for Patient With Chronic Low Back Pain (NCT00767806) | Eli Lilly and Company | 2008-09-01 |
| Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease (NCT00749216) | Eli Lilly and Company | 2008-09-01 |